Inscription Capital’s CVRx CVRX Stock Holding History

Inscription Capital’s Portfolio CVRX Stock Details CVRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,537	Closed	-$125K	–	736
2025 Q4	$125K	Buy	17,537 +283	+2%	+$2.58K	0.01%	637
2025 Q3	$139K	Buy	+17,254	New	+$130K	0.02%	598

Other funds holding CVRX

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GSK plc London $599M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Inscription Capital's CVRX Position: Q1 2026 in Review

Inscription Capital sold out of CVRx (CVRX) in Q1 2026, closing a stake of 17,537 shares — an estimated $125K sold.

Inscription Capital first reported a position in CVRX in Q3 2025 and held it in 2 quarters. The position peaked at $139K in Q3 2025. 99 funds tracked by Wall St. Rank hold CVRX as of Q1 2026.

Inscription Capital reported no remaining CVRx position as of Q1 2026 after selling out during the quarter.
Inscription Capital sold 17,537 CVRx shares in Q1 2026, an estimated $125K.
Inscription Capital first reported a position in CVRx in Q3 2025 and held it in 2 quarters.
Inscription Capital's CVRx position peaked at $139K in Q3 2025.
99 funds tracked by Wall St. Rank held CVRx as of Q1 2026.

Based on Inscription Capital's 13F filing for Q1 2026, filed 20 Apr 2026.